Navigation Links
Celebrity Golf Classic raises $553,443 for Seena Magowitz Foundation
Date:2/27/2012

PHOENIX, Ariz. Feb. 27, 2012 The 9th annual Seena Magowitz Celebrity Golf Classic raised $553,443 for pancreatic cancer research at the Translational Genomics Research Institute (TGen) through the Seena Magowitz Foundation.

These funds will go toward new international clinical trials run by TGen's Pancreatic Cancer Research Team.

This was the first time that major retailers, producers and suppliers in the mattress industry longtime supporters of pancreatic cancer research came together at the landmark Arizona Biltmore for the annual Seena Magowitz tournament.

More than 200 golfers took to the links Dec. 3, 2011, followed by an award luncheon, at which Roger E. Magowitz, President and co-founder of the Seena Magowitz Foundation, challenged everyone, the way he challenges himself.

"If not me, then who?" said Magowitz, a Scottsdale resident who for nearly a decade has championed research into finding a cure for pancreatic cancer, a disease that took the life of his mother, Seena, in 2001. "The 'who' is each one of you in this room," he said. "The 'who' is your business and your friends. The 'who' is an entire mattress industry united to fighting pancreatic cancer. I've never heard of any entire industry fighting a disease. We can beat this disease."

Magowitz, a long-time industry retailer, now is charitable advisor for Houston-based Mattress Firm, who has become a major sponsor.

Steve Stagner, President and CEO of Mattress Firm, a leading national bedding specialty retailer, served as Honorary Tournament Chairman: "This year's Seena Magowitz Classic provided us with a great opportunity to rededicate our commitment to putting an end to pancreatic cancer."

Michael Bassoff, President of the non-profit TGen Foundation, expressed his deep gratitude for the significant contributions made this past year by Roger Magowitz and Steve Stagner.

"In our fight against pancreatic cancer, there is no more powerful ally than Roger Magowitz, whose own commitment has initiated many incredible partnerships within the home furnishings industry," Bassoff said. "We also are extremely grateful to have merited the support of Steve Stagner and the Mattress Firm."

In March 2011, Mattress Firm announced that it named TGen its "charitable partner of choice," specifically funding TGen's pancreatic cancer research.

In May 2011, Mattress Firm kicked off their fundraising efforts for TGen's pancreatic cancer clinical trials.

In December 2011, pancreatic clinical trials began through TGen and other sites that are named for Seena Magowitz.


'/>"/>

Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a Perfect 10, Great Business Opp for Celebrity Retreat
2. New source of classical techniques for blood-based studies in the laboratory mouse
3. Editor of Springer classic human genetics reference receives prize
4. Study pinpoints genetic variation that raises a risk linked to bisphosphonates
5. Crowdfunding science: Student raises cash online to follow a flying fox
6. Paternity of subordinates raises cooperative effort in cichlids
7. Fading ability to taste iron raises health concerns for people over age 50
8. Extreme weight gain raises risk for recurrence among breast cancer survivors
9. Missing sugar molecule raises diabetes risk in humans
10. FASEB praises President Obama for increasing funding for research in his FY 2012 budget
11. New UCLA study raises questions about genetic testing of newborns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... DORTMUND, Germany , February 28, 2017 ... ... Amsterdam from 14 to 16 March, ... to destination, and show how seamless travel is a real benefit ... Materna has added biometrics to their passenger touch point solutions to ...
(Date:2/26/2017)... 25, 2017  Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring, announces the ... "Too often, too many offenders return ... jails are trying to tackle this ongoing problem ... and family members. While significant steps are underway, Securus ...
(Date:2/21/2017)... and PORTLAND, Ore. , Feb. ... the Avamere Family of Companies (Avamere Health Services, Infinity ... a six-month research study that will apply the power ... at senior living and health centers. By analyzing data ... to gain insights into physical and environmental conditions, and ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... Md. , March 23, 2017  Northwest ... developing DCVax® personalized immune therapies for solid tumor ... the $7.5 million financing it announced last Friday, ... sold to several institutional investors securities totaling 28,843,692 ... per share, and 10,000,000 shares of Class C ...
(Date:3/23/2017)... PARK, Calif., March 23, 2017  BioPharmX Corporation ... products for the dermatology market, today reported financial ... 31, 2017, and will provide an update on ... the year. "We are pleased to ... year for BioPharmX," said President Anja Krammer. "We ...
(Date:3/23/2017)... March 23, 2017 NetworkNewsWire Editorial Coverage  ... Cancer ... significant strain on health care systems, in terms of costs ... so too does the development of innovative and efficient therapies ... Among the many types of cancer treatments, a growing number ...
(Date:3/23/2017)... In today,s pre-market research, Stock-Callers.com ... Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals ... and Regulus Therapeutics Inc. (NASDAQ: RGLS ). ... its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more ... ...
Breaking Biology Technology: